Literature DB >> 25058373

A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation.

Reza Saleki1, Todd Christensen, Weihua Liu, Xiaowen Wang, Qing C Chen, Matthew Aakre, Nuno M V Gomes, Borislav A Alexiev, Joseph Schappert, Maria R Baer, Ying S Zou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25058373      PMCID： PMC4589160          DOI： 10.3109/10428194.2014.947611

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  9 in total

1.  MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia.

Authors:  Richard J Byers; Treeve Currie; Eleni Tholouli; Scott J Rodig; Jeffery L Kutok
Journal:  Blood       Date:  2011-07-13       Impact factor: 22.113

Review 2.  GAB2--a scaffolding protein in cancer.

Authors:  Sarah J Adams; Iraz T Aydin; Julide T Celebi
Journal:  Mol Cancer Res       Date:  2012-08-07       Impact factor: 5.852

3.  Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.

Authors:  Michael G Kharas; Christopher J Lengner; Fatima Al-Shahrour; Lars Bullinger; Brian Ball; Samir Zaidi; Kelly Morgan; Winnie Tam; Mahnaz Paktinat; Rachel Okabe; Maricel Gozo; William Einhorn; Steven W Lane; Claudia Scholl; Stefan Fröhling; Mark Fleming; Benjamin L Ebert; D Gary Gilliland; Rudolf Jaenisch; George Q Daley
Journal:  Nat Med       Date:  2010-07-08       Impact factor: 53.440

Review 4.  The pathobiology of the septin gene family.

Authors:  Peter A Hall; S E Hilary Russell
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

5.  A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23).

Authors:  Aikaterini Barbouti; Mattias Höglund; Bertil Johansson; Carin Lassen; Per-Gunnar Nilsson; Anne Hagemeijer; Felix Mitelman; Thoas Fioretos
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

6.  EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22.

Authors:  An De Weer; Frank Speleman; Barbara Cauwelier; Nadine Van Roy; Nurten Yigit; Bruno Verhasselt; Barbara De Moerloose; Yves Benoit; Lucien Noens; Dominik Selleslag; Eric Lippert; Stephanie Struski; Christian Bastard; Anne De Paepe; Peter Vandenberghe; Anne Hagemeijer; Nicole Dastugue; Bruce Poppe
Journal:  Haematologica       Date:  2008-09-24       Impact factor: 9.941

7.  Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

Authors:  Jan Cools; Iwona Wlodarska; Riet Somers; Nicole Mentens; Florence Pedeutour; Brigitte Maes; Christiane De Wolf-Peeters; Patrick Pauwels; Anne Hagemeijer; Peter Marynen
Journal:  Genes Chromosomes Cancer       Date:  2002-08       Impact factor: 5.006

8.  High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.

Authors:  Qitian Mu; Yungui Wang; Bing Chen; Wenbin Qian; Haitao Meng; Hongyan Tong; Feifei Chen; Qiuling Ma; Wanmao Ni; Saijuan Chen; Jie Jin
Journal:  Leuk Res       Date:  2013-06-04       Impact factor: 3.156

9.  Regulation of myeloid leukaemia by the cell-fate determinant Musashi.

Authors:  Takahiro Ito; Hyog Young Kwon; Bryan Zimdahl; Kendra L Congdon; Jordan Blum; William E Lento; Chen Zhao; Anand Lagoo; Gareth Gerrard; Letizia Foroni; John Goldman; Harriet Goh; Soo-Hyun Kim; Dong-Wook Kim; Charles Chuah; Vivian G Oehler; Jerald P Radich; Craig T Jordan; Tannishtha Reya
Journal:  Nature       Date:  2010-07-18       Impact factor: 49.962
  9 in total
  9 in total

1.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Authors:  Sun-Mi Park; Mithat Gönen; Ly Vu; Gerard Minuesa; Patrick Tivnan; Trevor S Barlowe; James Taggart; Yuheng Lu; Raquel P Deering; Nir Hacohen; Maria E Figueroa; Elisabeth Paietta; Hugo F Fernandez; Martin S Tallman; Ari Melnick; Ross Levine; Christina Leslie; Christopher J Lengner; Michael G Kharas
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

Review 2.  Stem Cells, Cancer, and MUSASHI in Blood and Guts.

Authors:  Michael G Kharas; Christopher J Lengner
Journal:  Trends Cancer       Date:  2017-04-08

3.  Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.

Authors:  Sujitha Duggimpudi; Andreas Kloetgen; Sathish Kumar Maney; Philipp C Münch; Kebria Hezaveh; Hamed Shaykhalishahi; Wolfgang Hoyer; Alice C McHardy; Philipp A Lang; Arndt Borkhardt; Jessica I Hoell
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

4.  The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.

Authors:  Kun Guo; Jiujie Cui; Ming Quan; Dacheng Xie; Zhiliang Jia; Daoyan Wei; Liang Wang; Yong Gao; Qingyong Ma; Keping Xie
Journal:  Clin Cancer Res       Date:  2016-07-22       Impact factor: 12.531

5.  Rare copy number variants analysis identifies novel candidate genes in heterotaxy syndrome patients with congenital heart defects.

Authors:  Chunjie Liu; Ruixue Cao; Yuejuan Xu; Tingting Li; Fen Li; Sun Chen; Rang Xu; Kun Sun
Journal:  Genome Med       Date:  2018-05-30       Impact factor: 11.117

6.  Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.

Authors:  Gerard Minuesa; Steven K Albanese; Wei Xie; Yaniv Kazansky; Daniel Worroll; Arthur Chow; Alexandra Schurer; Sun-Mi Park; Christina Z Rotsides; James Taggart; Andrea Rizzi; Levi N Naden; Timothy Chou; Saroj Gourkanti; Daniel Cappel; Maria C Passarelli; Lauren Fairchild; Carolina Adura; J Fraser Glickman; Jessica Schulman; Christopher Famulare; Minal Patel; Joseph K Eibl; Gregory M Ross; Shibani Bhattacharya; Derek S Tan; Christina S Leslie; Thijs Beuming; Dinshaw J Patel; Yehuda Goldgur; John D Chodera; Michael G Kharas
Journal:  Nat Commun       Date:  2019-06-19       Impact factor: 14.919

Review 7.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

8.  The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.

Authors:  Jason R Schwartz; Jing Ma; Jennifer Kamens; Tamara Westover; Michael P Walsh; Samuel W Brady; J Robert Michael; Xiaolong Chen; Lindsey Montefiori; Guangchun Song; Gang Wu; Huiyun Wu; Cristyn Branstetter; Ryan Hiltenbrand; Michael F Walsh; Kim E Nichols; Jamie L Maciaszek; Yanling Liu; Priyadarshini Kumar; John Easton; Scott Newman; Jeffrey E Rubnitz; Charles G Mullighan; Stanley Pounds; Jinghui Zhang; Tanja Gruber; Xiaotu Ma; Jeffery M Klco
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

9.  Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS.

Authors:  Anna Stengel; Rabia Shahswar; Torsten Haferlach; Wencke Walter; Stephan Hutter; Manja Meggendorfer; Wolfgang Kern; Claudia Haferlach
Journal:  Blood Adv       Date:  2020-11-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.